This inventor holds 1 USPTO granted patent. Top assignees: The State University of New York, US Government as Represented by the Secretary of the Army. Active years: 2021.
Company Filing History:
1 out of 2,044 
1 out of 8,745 
Years Active: 2021
Title: Rafael De La Barrera: Innovator in Zika Virus Vaccine Development
Introduction
Rafael De La Barrera is a notable inventor based in Washington, DC, recognized for his significant contributions to medical science. He has developed a patent that addresses a critical public health issue, specifically targeting the Zika virus.
Latest Patents
De La Barrera holds a patent for a Zika virus vaccine and methods of production. The invention generally relates to a purified inactivated Zika virus (ZIKV), methods for producing the purified inactivated ZIKV, immunogenic compositions, and vaccines comprising the purified inactivated ZIKV. This innovation plays a vital role in the prevention and treatment of infections caused by ZIKV.
Career Highlights
Throughout his career, De La Barrera has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the State University of New York. His work has been instrumental in advancing vaccine development and public health initiatives.
Collaborations
Some of his notable coworkers include Stephen J. Thomas and Timothy Endy, who have contributed to the research and development efforts in the field of infectious diseases.
Conclusion
Rafael De La Barrera's innovative work in developing a Zika virus vaccine highlights his commitment to addressing global health challenges. His contributions are essential in the ongoing fight against infectious diseases, showcasing the importance of innovation in medical research.